Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Star Lake Bioscience Co was 71.00% per year. The lowest was -24.20% per year. And the median was 9.20% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Star Lake Bioscience Co (SHSE:600866) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Star Lake Bioscience Co Forward Dividend Yield % Related Terms
SHSE:600866 vs VRTX, REGN, ALNY: Forward Dividend Yield % Comparison
For the Biotechnology subindustry, Star Lake Bioscience Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Star Lake Bioscience Co Forward Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Star Lake Bioscience Co's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Star Lake Bioscience Co's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 7.54% mean?
Star Lake Bioscience Co (SHSE:600866) has a Forward Dividend Yield % of 7.54% as of Jul. 17, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Star Lake Bioscience Co and its competitors. According to the industry distribution chart, Star Lake Bioscience Co ranks #999999 out of 148 companies in the Biotechnology industry.
Is Star Lake Bioscience Co's Forward Dividend Yield % too high?
Star Lake Bioscience Co's current Forward Dividend Yield % is 7.54%. The Biotechnology industry median Forward Dividend Yield % is 1.32. Star Lake Bioscience Co's value of 7.54% is 473.4% above this industry median. Based on the distribution chart, Star Lake Bioscience Co ranks #999999 out of 148 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Star Lake Bioscience Co has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Star Lake Bioscience Co's Forward Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Star Lake Bioscience Co ranks #999999 out of 148 companies for Forward Dividend Yield %. This places Star Lake Bioscience Co in the lower half of its industry. The industry median Forward Dividend Yield % is 1.32. Star Lake Bioscience Co's value of 7.54% is 473.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.32, based on 148 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Star Lake Bioscience Co's current Forward Dividend Yield % of 7.54% is 473.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Star Lake Bioscience Co and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Star Lake Bioscience Co's current Forward Dividend Yield % is 7.54%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Star Lake Bioscience Co stock overvalued right now?
Based on GuruFocus' analysis, Star Lake Bioscience Co (SHSE:600866) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥5.86, compared to a current price of ¥5.01 — trading 14.5% below its estimated fair value. The current Forward Dividend Yield % is 7.54% and 473.4% above the Biotechnology industry median of 1.32. Star Lake Bioscience Co's overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Star Lake Bioscience Co (SHSE:600866), the current Forward Dividend Yield % is 7.54% as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Star Lake Bioscience Co (SHSE:600866) Overvalued in 2026?
Based on GuruFocus' analysis, Star Lake Bioscience Co stock appears to be undervalued.
The current stock price of ¥5.01 is trading 14.5% below its estimated GF Value™ of ¥5.86.
GuruFocus considers Star Lake Bioscience Co to be Modestly Undervalued.
Key valuation signals for SHSE:600866:
Forward Dividend Yield %: 7.54%
GF Value™: ¥5.86 vs. price of ¥5.01 (14.5% below fair value)
Industry Position: 473.4% above the Biotechnology median (#999999 of 148)
No single metric tells the full story. See the SHSE:600866 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.
70GF Score
Get the complete analysis for SHSE:600866
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600866 has been successfully added to your 
